News Jun 12, 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
总部 Jun 27, 2023 设立您的公司总部 您是一家寻求进入欧洲市场的生物制药公司吗?瑞士可能是设立商业总部或区域中心的理想地点,可帮助您的企业覆盖整个欧洲,以及欧洲、中东和非洲市场的运营。瑞士的吸引力包括地处欧洲中心的战略位置、商业友好型的营商环境、有竞争力的公司和个人税收制度以及多样化的人才市场。默克雪兰诺(Merck Sero...
News May 09, 2023 Siegfried acquires majority in DiNAMIQS Siegfried has acquired a stake of 95 percent in DiNAMIQS. The global life sciences firm is planning to bring the development and production platf...
News Feb 14, 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News May 20, 2022 BeiGene opens European headquarters in Basel BeiGene has opened its new European headquarters in Basel. The global biotech company specializing in innovative cancer treatments intends to bui...
News Mar 14, 2023 Absci relocating innovation from North America to the Greater Zurich Area Absci is establishing an innovation center in the Greater Zurich Area. The existing talent and technology ecosystem in the region should help the...
News Mar 08, 2023 Oculis lists on Nasdaq with strong clinical-stage pipeline in ophthalmology Oculis Holding AG, a global biopharmaceutical company focused on saving sight and improving eye care, has announced its listing on the Nasdaq sto...
Actualités Sep 29, 2023 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
News Oct 17, 2022 Escientia Switzerland becomes Primopus The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The Swiss subsidiary of America’s Esc...
News Dec 11, 2023 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
News Oct 06, 2022 Biopôle expands further with the construction of three new buildings Biopôle has announced that Edmond de Rothschild Real Estate SICAV will be investing in the construction of three new buildings on the campus in E...
News Jan 11, 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
News Jul 06, 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
Aktuell Jun 02, 2023 Neuste Forschung zeigt, dass 20% der europäischen Biotechs ihren Hauptsitz in der Schweiz haben Press release Neue Untersuchungen von IQVIA, die kürzlich im Swiss Biotech Report 2023 veröffentlicht wurden, zeigen, dass mittlerweile 20% der europäischen Bi...
News Jun 21, 2022 KBI Biopharma and Selexis open a new biologics manufacturing facility in Geneva KBI Biopharma and Selexis, both JSR Life Sciences companies, announced that an expanded, fully-integrated mammalian contract development and manu...
News May 26, 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News May 03, 2022 Why Switzerland’s pioneering role in blockchain combined with its biotech heritage makes it a source of innovation With the rise of new technologies such as blockchain and AI, the pragmatic regulatory approach of the Swiss authorities has become an important a...
News May 18, 2022 Cell and gene therapy specialist Cytiva opens new facility in Grens Global life sciences leader Cytiva is opening a new manufacturing in Grens, which will also house the company’s Center of Excellence for cell and...